Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial. [electronic resource]
Producer: 20090212Description: 442-9 p. digitalISSN:- 1532-1827
- Aged
- Aged, 80 and over
- Androstadienes -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Aromatase Inhibitors -- therapeutic use
- Breast Neoplasms -- drug therapy
- Combined Modality Therapy
- Disease Progression
- Female
- Humans
- Middle Aged
- Postmenopause
- Receptors, Estrogen -- metabolism
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.